Biomerica reported $1,034,450 in first quarter net sales, compared to $1,013,739 in the same period last year.
The company reported a net loss of $219,268, primarily due to an increase in research and development. The majority of research and development funds were focused on the company’s new gastroenterology test.
More articles on gastroenterology:
ACG, Smart Clinic strike deal for software marketing, distribution
11 statistics on gastroenterologist & payer relationships
3 ways gastroenterologists can demonstrate value
